Article
Emerging evidence of molecular biomarkers in hepatocellular carcinoma.
1 Apr 2018
Abstract excerpt
Hepatocellular carcinoma (HCC) is the third most common cause of cancer-related death worldwide. Patients with HCC generally present at an advanced stage resulting in death within 6-20 months. Therefore, novel treatment modalities and sensitive prognostic markers that can decrease the mortality rate of HCC are required. HCC is a complex and heterogeneous tumor with multiple genetic aberrations. It has been well...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
